My mother also had osteoporosis.
New evidence shows that extended estrogen suppression treatment using an aromatase inhibitors for hormone receptor-positive postmenopausal breast cancer is safe; it does not increase the risk of ...
High blood pressure, or hypertension, affects more than one billion people worldwide and is a leading cause of heart disease ...
A new study from researchers at Baylor College of Medicine brings hope for a more personalized approach to treat estrogen receptor-positive (ER+) breast cancer, the most common type of this cancer.
Hosted on MSN
Biomarker brings ER+ breast cancer patients one step closer to more personalized therapy
A new study by researchers at Baylor College of Medicine brings hope for a more personalized approach to treating estrogen receptor-positive (ER+) breast cancer, the most common type of this cancer.
What is Inluryo, and who can benefit from it? Learn about this newly approved breast cancer treatment and how it works.
About 95% of women reported symptom relief following this treatment THURSDAY, Nov. 20, 2025 (HealthDay News) — Plasma infusions may help breast cancer survivors avoid genital and urinary symptoms ...
An estrogen-like drug, raloxifene, has no demonstrated benefit on memory and thinking skills for women with dementia due to Alzheimer's disease, according to a study published in the November 4, 2015, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results